Francesco Giotta

22PUBLICATIONS
109CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Sep 04, 2025
Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.

Federica Miglietta, Manon De Graaf, Claudio Vernieri

|Feb 26, 2025
Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows.

Bianca Medici, Eugenia Caffari, Yuri Maculan

|Jan 27, 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments.

Lorenzo Belluzzi, Giulio Martinelli, Bianca Medici

|Mar 13, 2024
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.

Fabio Canino, Antonio Tornincasa, Stefania Bettelli

Pageof 4

Frequent Collaborators

7 joint publications

Maria Vittoria Dieci

5 joint publications

Angela Toss

5 joint publications

Gaia Griguolo

4 joint publications

Valentina Guarneri